Bernstein Liebhard LLP Applauds FDA’s Safety Communication on Transvaginal Mesh

Share Article

Bernstein Liebhard LLP is pleased to report that on July 13, 2011, the U.S. Food and Drug Administration issued a public notice, warning health care providers to consider alternative options to transvaginal mesh when treating Pelvic Organ Prolapse because of life-threatening risks associated with the surgical implant.

Bernstein Liebhard LLP, a staunch advocator for those injured by defective medical devices, supports the latest action taken by the U.S. Food and Drug Administration (“FDA”), warning consumers of the dangers associated with transvaginal mesh (“TVM”). It is our opinion that the FDA’s ongoing review of TVM is beneficial as it will help consumers make informed decisions and ultimately benefit the safety and welfare of those affected by Pelvic Organ Prolapse (“POP”). Specifically, on July 13, 2011, the FDA issued a safety communication advising patients and doctors to consider alternative treatments to TVM. Additionally, the FDA announced that it will convene to discuss whether TVM should be removed from the market. Further, the FDA recommended that women suffering from POP refrain from undergoing surgical placement of TVM because the implants expose them to an increased risk of sustaining serious and fatal injuries.

TVM is a device that is surgically implanted into the vaginal wall to treat complications occurring after childbirth and pregnancy. According to the FDA announcement, in 2010, an estimated 75,000 women received TVM implants in order to repair POP, a common condition in which a woman’s uterus, bladder or rectum, change position. The FDA announcement also noted that studies have shown that women who receive TVM implants are more likely to suffer mesh erosion, as well as other complications that require additional surgeries to remove the mesh.    

In 2008, the FDA issued its first communication regarding the dangers associated with TVM, and has since continued to review the safety of the devices. Since that time, Bernstein Liebhard LLP has provided a wealth of consumer information concerning TVM on its website, If you or a loved one underwent a surgical procedure and have been implanted with TVM, you may be entitled to compensation for medical bills, pain and suffering, lost wages and other injuries.

For more information about filing a TVM lawsuit, contact an attorney at Bernstein Liebhard LLP at (877) 779-1414 or at info(at)consumerinjurylawyers(dot)com.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2011 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern